Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AZN
AZN logo

AZN News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AZN News

FDA Accelerates Biosimilar Drug Development and Approves New Treatments

12h agoNASDAQ.COM

AstraZeneca's Antibody Therapy Achieves Phase 3 Trial Success

3d agoseekingalpha

First IL-33-Targeting Biologic Shows Significant Reduction in COPD Exacerbations

3d agoNewsfilter

AstraZeneca Reports Positive COPD Trial Results

3d agoNASDAQ.COM

AstraZeneca and Sanofi Expand R&D Operations in China

Mar 20 2026seekingalpha

Senhwa Biosciences Achieves Breakthrough in Photodynamic Therapy

Mar 17 2026Yahoo Finance

Andrew Hamilton Acquires Omeprazole.com Domain

Mar 17 2026Yahoo Finance

AstraZeneca and Daiichi Sankyo Secure US Priority Review for Enhertu

Mar 15 2026Yahoo Finance

AZN Events

03/27 16:30
Major Averages Drop Due to Strait of Hormuz Incidents
The major averages capped a down week with a sharp leg lower, as incidents in the Strait of Hormuz exacerbated traders' energy supply concerns despite President Trump saying he will hold off on further attacks on energy infrastructure in Iran. Oil prices are rising again, with Brent crude trading above $110 per barrel. Meanwhile, the Wall Street Journal reported that the Pentagon is considering sending another 10,000 ground troops to the Middle East, even as President Trump said he is pausing Iran "energy plant destruction" plans until April 6.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Carnivalreported, announced a new set of long-term targets, and announced an initial $2.5B share buyback program, but trimmed its annual profit target due to higher fuel costsUnityraisedand said it will sunset ironSource Ads NetworkAstraZenecasaid its COPD treatment tozorakimabin Phase 3 trialsNovartisbiotech company Excellergy for up to $2BEntergy Louisianaannounced awith Meta2. WALL STREET CALLS:TripAdvisorto Buy at BofA on "clearer catalyst path"Primo Brandsto Buy at JefferiesWix.comto Underweight at JPMorganBilibilito Buy at Citi following share price correctionUpstream Bioto In Line at Evercore ISI3. AROUND THE WEB:Citiis weighing acquiring a U.S. regional bank, Bloomberg reportsRivianhas completed winter testing of the VW ID. EVERY1, triggering a $1B investment from Volkswagen, TechCrunch reportsAmerican Airlinesis in discussions with SpaceX's Starlink and Amazonto overhaul its in-flight internet and entertainment, CNBC saysApplegranted out-of-cycle bonuses worth several hundred thousand dollars to iPhone hardware designers, as OpenAI and others poach its engineers, Bloomberg reportsCarlyleand KKRhave been selected by the U.S. Army to build two data centers on military bases that are estimated to cost $2B each, FT says4. MOVERS:Adma Biologicsincreases after responding to theKopingains afterBrown-Formanhigher afterwith Pernod RicardSatellogiclower after reporting a subcontract agreement withLithium Argentinafalls in New York after5. EARNINGS/GUIDANCE:Super League Enterprise, with EPS beating consensusAutolus, with CEO Christian Itin commenting, "Autolus had a strong first year of launch of AUCATZYL in the US"Legence, with EPS missing consensusSanuwave Healthand provided guidance for Q1 and FY26SBC Medical, with EPS beating consensusINDEXES:The Dow fell 793.47, or 1.73%, to 45,166.64, the Nasdaq lost 459.72, or 2.15%, to 20,948.36, and the S&P 500 declined 108.31, or 1.67%, to 6,368.85.
03/27 12:00
Major Averages Decline Amid Middle East Tensions
The major averages were broadly lower once again amid tensions in the Middle East, as incidents in the Strait of Hormuz exacerbated traders' energy supply concerns. Oil prices are rising again, with Brent crude trading above $110 per barrel. Meanwhile, the Wall Street Journal reported that the Pentagon is considering sending another 10,000 ground troops to the Middle East, even as President Trump said he is pausing Iran "energy plant destruction" plans until April 6.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Carnivalreported, announced a new set of long-term targets, and announced an initial $2.5B share buyback program, but trimmed its annual profit target due to higher fuel costsUnityraised itsand said it will sunset ironSource Ads NetworkAstraZenecasaid its COPD treatment tozorakimabin Phase 3 trialsNovartisbiotech company Excellergy for up to $2BEntergy Louisianaannounced awith Meta2. WALL STREET CALLS:TripAdvisorto Buy at BofA on "clearer catalyst path"Primo Brandsto Buy at JefferiesWix.comto Underweight at JPMorganBilibilito Buy at Citi following share price correctionUpstream Bioto In Line at Evercore ISI3. AROUND THE WEB:BASFhas sold a $290.6M stake in Harbour Energy through a share placing, WSJ reportsAmerican Airlinesis in discussions with SpaceX's Starlink and Amazonto overhaul its in-flight internet and entertainment, CNBC saysApplegranted out-of-cycle bonuses worth several hundred thousand dollars to iPhone hardware designers, as OpenAI and others poach its engineers, Bloomberg reportsCarlyleand KKRhave been selected by the U.S. Army to build two data centers on military bases that are estimated to cost $2B each, FT saysVolkwagen'spartnership with Rivianhas passed a key milestone, with winter tests of the first vehicles using the software successfully completed, Reuters reports4. MOVERS:Adma Biologicsincreases after responding to theby Culper ResearchKopingains afterBrown-Formanhigher afterwith Pernod RicardSatellogiclower after reporting awith Innovative Defense TechnologiesLithium Argentinafalls in New York after announcing a5. EARNINGS/GUIDANCE:Super League Enterprise, with EPS beating consensusAutolus, with CEO Christian Itin commenting, "Autolus had a strong first year of launch of AUCATZYL in the US"Legence, with EPS missing consensusSanuwave Healthand provided guidance for Q1 and FY26SBC Medical, with EPS beating consensusINDEXES:Near midday, the Dow was down 0.68%, or 313.71, to 45,646.40, the Nasdaq was down 1.06%, or 227.67, to 21,183.49, and the S&P 500 was down 0.68%, or 44.13, to 6,433.03.
03/27 09:00
Stock Futures Modestly Lower as Energy Prices Rise
Stock futures are modestly lower ahead of the open, indicating a weaker start. The move follows another sharp decline in the prior session, where the S&P 500 fell more than 1% and the Nasdaq dropped over 2%, moving into correction territory.The primary driver remains energy. Oil prices are rising again, with Brent crude trading above $110 per barrel. Although prices are on track for a slight weekly decline, they remain significantly elevated due to ongoing supply disruptions tied to the Iran conflict.That persistence in elevated oil prices is continuing to feed into broader market conditions. Treasury yields are climbing, with the 10-year approaching the mid-4% range, and rate expectations have shifted meaningfully. Markets that previously anticipated rate cuts are now pricing in the possibility of further tightening, reflecting concern that the energy shock could keep inflation elevated.In pre-market trading, S&P 500 futures fell 0.45%, Nasdaq futures fell 0.67% and Dow futures fell 0.39%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -AstraZenecaup 4% after announcing tozorakimab met the primary endpoint in OBERON and TITANIA trialsUP AFTER EARNINGS -Newsmaxup 12%Arganup 10%Legenceup 9%BioXcel Therapeuticsup 3%DOWN AFTER EARNINGS -Humacytedown 7%P3 Health Partnersdown 6%Autolus Therapeuticsdown 4%Laird Superfooddown 4%LOWER -Two Harborsdown 1% after entering into a definitive merger agreement pursuant to which CrossCountry will acquire all of the outstanding shares of Two Harbors common stock for $10.80 per share in cash

AZN Monitor News

AstraZeneca's tozorakimab shows success in COPD trials

Mar 27 2026

AstraZeneca Expands R&D Operations in China

Mar 20 2026

AstraZeneca Awards $3.4 Million to Nonprofits for Health Equity Initiatives

Feb 11 2026

AstraZeneca Raises FY 2026 Revenue Guidance Amid Strong Q4 Results

Feb 10 2026

AstraZeneca's DATROWAY Receives FDA Priority Review for TNBC

Feb 06 2026

AstraZeneca to Invest $15 Billion in China and Partner with CSPC

Feb 02 2026

AstraZeneca to Delist from Nasdaq, Transition to NYSE

Jan 20 2026

AstraZeneca's Saphnelo Shows Positive Phase 3 Results

Jan 06 2026

AZN Earnings Analysis

AstraZeneca Earnings: 2025 Growth & Strategic Innovations- Intellectia AI™
4 months ago
AstraZeneca's Impressive Q4 2024 Performance: A Detailed Earnings Review - Intellectia AI™
1 years ago
AstraZeneca Reports Financial Results for Q3 2024
1 years ago

People Also Watch